ArticleMicrobial genomics2026
Full-genome analysis of emerging Coxsackievirus B4 genotype D strains associated with herpangina in eastern China.
Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2024 herpangina surveillance in Yuhuan City, China, two Coxsackievirus B4 strains (Z168, Z296) were identified. Full-length genome sequencing revealed that both strains belonged to genotype D that was first documented in eastern China. The two strains showed the highest nucleotide similarity to Coxsackievirus B4 strains isolated in the UK (2017). In the recombination events, both major parental strains were identified as Coxsackievirus B4 strains isolated in France (2015 and 2017). Echovirus 11 and Coxsackievirus B5 were detected as minor parental strains, indicating intertypic recombination. Phylogenetically, Z168 and Z296 clustered closely with European genotype D strains (2013-2024) but were distant from previously reported Chinese genotype D strains (Yunnan 2013-2016; Tianjin 2019). Bayesian phylogeographic reconstruction suggested a complex global transmission history of Coxsackievirus B4 with increasing cross-border transmission in recent decades, including genotypes A, D and E transmitting among North America, Europe and Asia. Both strains possessed a unique amino acid substitution within a putative neutralizing epitope, suggesting potential antigenic evolution. These findings indicate that the Z168 and Z296 strains likely represent a recent European introduction, forming a lineage distinct from earlier Chinese genotype D isolates. This highlights the need for molecular surveillance to track Coxsackievirus B4 emergence and evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.